Enhanced steatosis by nuclear receptor ligands: A study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile

被引:72
作者
Moya, Marta [1 ]
Jose Gomez-Lechon, M. [1 ]
Castell, Jose V. [1 ,2 ]
Jover, Ramiro [1 ,2 ]
机构
[1] Hosp Univ La Fe, Ctr Invest, Unidad Hepatol Expt, Valencia, Spain
[2] Univ Valencia, Fac Med, Dept Bioquim & Biol Mol, E-46003 Valencia, Spain
关键词
Nuclear receptor ligands; Fatty acids; Steatosis; NAFLD; Cultured human hepatocytes; HepG2; NONALCOHOLIC FATTY LIVER; CONSTITUTIVE ANDROSTANE RECEPTOR; PREGNANE-X-RECEPTOR; PROLIFERATOR-ACTIVATED RECEPTORS; PPAR GAMMA 1; LIPID-METABOLISM; GENE-EXPRESSION; ADIPOSE-TISSUE; ACID SYNTHESIS; CHOLESTEROL;
D O I
10.1016/j.cbi.2010.01.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Steatosis is the first step in the development of non-alcoholic fatty liver disease (NAFLD). However, the mechanisms involved in its pathogenesis are not fully understood. Many nuclear receptors (NRs) involved in energy homeostasis and biotransformation constitute a network connecting fatty acids, cholesterol and xenobiotic metabolisms: therefore, multiple NRs and their ligands may play a prominent role in liver fat metabolism and accumulation. In this study we have attempted to gain insight into the relevance of the NR superfamily in NAFLD by investigating the steatogenic potential of 76 different NR ligands in fatty acid overloaded human hepatocytes and hepatoma cells. Moreover, we have determined the mRNA expression level of 24 NRs to correlate the steatogenic potential of the ligands with the expression of their associated NRs in the cultured cells. Our results demonstrate that 18% of the examined NR ligands enhanced lipid accumulation in human hepatocytes and/or hepatoma cells. Among them, ligands of PPAR-gamma (e.g., thiazolidinediones), LXR (paxilline and 24(S),25-epoxycholesterol), PXR (hyperforin), CAR (3 alpha,5 alpha-androstenol), ER alpha (tamoxifen), FXR (Z-guggulsterone), VDR (25-hydroxyvitamin D3) and particular retinoids and farnesoids showed a significant pro-steatotic effect. The mRNA level of most of the NRs examined was well preserved in human hepatocytes, but HepG2 showed a deranged profile, where many of the receptors had a marginal or negligible level of expression in comparison with the human liver. By comparing the steatogenic effect of NR ligands with the NR expression levels, we conclude that LXR, PXR, RAR and PPAR gamma ligands likely induce fat accumulation by a NR-dependent mechanism. Indeed, overexpression of PXR in HepG2 cells enhanced the steatogenic effect of hyperforin and rifampicin. However, the accumulation of fat induced by other ligands did not correlate with the expression of their associated NR. Our results also suggest that human hepatocytes cultured with free fatty acids offer a highly valuable in vitro system to investigate the pathogenesis and therapeutics of the human fatty liver. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:376 / 387
页数:12
相关论文
共 73 条
[1]   Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats [J].
Alvaro, D ;
Alpini, G ;
Onori, P ;
Perego, L ;
Baroni, GS ;
Franchitto, A ;
Baiocchi, L ;
Glaser, SS ;
Le Sage, G ;
Folli, F ;
Gaudio, E .
GASTROENTEROLOGY, 2000, 119 (06) :1681-1691
[2]   Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis [J].
Anderson, Nora ;
Borlak, Juergen .
PHARMACOLOGICAL REVIEWS, 2008, 60 (03) :311-357
[3]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[4]   Mouse models in non-alcoholic fatty liver disease and steatohepatitis research [J].
Anstee, QM ;
Goldin, RD .
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2006, 87 (01) :1-16
[5]   Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists [J].
Barkhem, T ;
Carlsson, B ;
Nilsson, Y ;
Enmark, E ;
Gustafsson, JÅ ;
Nilsson, S .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :105-112
[6]   Constitutive androstane receptor agonist, TCPOBOP, attenuates steatohepatitis in the methionine choline-deficient diet-fed mouse [J].
Baskin-Bey, Edwina S. ;
Anan, Akira ;
Isomoto, Hajime ;
Bronk, Steven F. ;
Gores, Gregory J. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (42) :5635-5641
[7]   Nuclear receptors in lipid metabolism: Targeting the heart of dyslipidemia [J].
Beaven, SW ;
Tontonoz, P .
ANNUAL REVIEW OF MEDICINE, 2006, 57 :313-329
[8]   Nuclear receptors and their relevance to diseases related to lipid metabolism [J].
Berkenstam, A ;
Gustafsson, JK .
CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (02) :171-176
[9]   Overview of retinoid metabolism and function [J].
Blomhoff, Rune ;
Blomhoff, Heidi Kiil .
JOURNAL OF NEUROBIOLOGY, 2006, 66 (07) :606-630
[10]   Guggulsterone activates multiple nuclear receptors and induces CYP3A gene expression through the pregnane X receptor [J].
Brobst, DE ;
Ding, XS ;
Creech, KL ;
Goodwin, B ;
Kelley, B ;
Staudinger, JL .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (02) :528-535